Targeting Advanced Breast Cancer
The FDA approved a molecularly targeted therapeutic for postmenopausal women with HR-positive, HER2-negative breast cancer. The U.S. Food and...
Progress Against Cancer
The FDA approved a molecularly targeted therapeutic for postmenopausal women with HR-positive, HER2-negative breast cancer. The U.S. Food and...
The U.S. Food and Drug Administration action means ibrutinib is now an approved treatment for three types of non-Hodgkin...
The U.S. Food and Drug Administration decision means nivolumab is now an approved treatment for six types of cancer....
The newly approved therapeutic is for treating women whose cancers test positive for BRCA1 and BRCA2 mutations with a...
The U.S. Food and Drug Administration decision means nivolumab is now an approved treatment for five types of cancer....
Adding the newly approved therapeutic to standard treatment improved survival for patients with advanced disease. The U.S. Food and...
The U.S. Food and Drug Administration approval means there are now three immunotherapeutics called checkpoint inhibitors approved for treating...
The U.S. Food and Drug Administration approval provides a new treatment option for patients with the most common type...
The FDA-approved diagnostic test uses blood samples to look for specific mutations in certain patients with metastatic lung cancer....
The approval provides the first new treatment option in more than 30 years for patients with the most common...